Houston's DataCon can help prepare business leaders for the digital revolution in AI and machine learning. Getty Images

Looming on the horizon is a data tsunami coming towards us at breakneck speed. Companies have worked hard to keep up, creating digital transformation, taking manual processes from desktops, clipboards, and the paper paradigm to the Cloud. We're now sitting on huge quantities of idle bits of information called dark data. It's over collected and unused data that has the potential power to create decision-making brilliance.

Business leaders are attempting to optimize siloed data – unrelated data collected in databases and spreadsheets or obsolete apps, to make critical decisions. We currently connect these siloes with other systems using a data processing step called ETL – Extract, Transform and Load. Take the data from one place, transform it so it can relate to another data resource and then load that data to another place for analysis. It's a big, time consuming, intermediary step we have figured out how to circumvent. "NoETL" technology is the next-generation magic wand of machine thinking and it's a game-changer.

As non-technical business leaders, we rely on our partners in IT to give us meaningful data that charts our course. They've been our faithful navigators. We've made the recommended investment in IT infrastructure and technology and counted on receiving analytics that will result in winning outcomes. It's now time to sit down at the table and have new conversations with IT leadership around AI.

A tectonic shift

We are now in a new place. AI has come upon us quickly and the promise of ROI is great. There are new technologies that give business leaders advantages never before realized. Data science is the new crystal ball to the future of business. Automation and machine learning are taking historical data to a look ahead using algorithms and mathematical modeling. It's a new predictive mindset. What business leader wouldn't want that crystal ball?

The real assets of your business exist not in better machines but in your current data stores which are like coal mines waiting for data science to turn those lumps of coal into data diamonds.

There are new vocabulary words associated with data analytics. Data science thought leaders are preparing the way for businesses to have learning opportunities and to know which resources to tap for direction in creating new competitive dynamics. Don't wait too long to be curious. The early adopters are already a step ahead and the competitive marketplace is changing in unexpected ways.

Leadership resources for the implementation of AI

Legacy businesses with data lakes are ripe for action. Who should lead the charge? It's up to the C-suite to have intentional conversations around data science. It's up to leadership to be ready to speak and understand new concepts and vocabulary combined with leaps of faith needed to join the new world order of information.

Learning resources 

Proactively look for learning opportunities. There are no excuses for not taking the initiative. No matter where you are in your career – this isn't something to linger about.

One upcoming seminar around AI and automation collaboration and education is DataCon Houston. It's an annual conference that brings important concepts around AI and Automation to business leaders. The target audience is not IT professionals, although there will be some in attendance; it's meant primarily to help the C-suite and non-technical leaders know where to begin and where to find that new vocabulary and translative resources. AI will affect every person in every business, and we must be ready for the cultural shifts that will come with the technological shifts.

Authors and thought leaders — George Danner, Dave McComb, and Gerald Kane will be speaking at DataCon October 10, 2019. In addition, Javier Fadul, director of innovation for HTX Labs will be speaking about XR and data visualization and its use in training employees and creating safer workplaces. Stefanos Damianakis will be teaching machine learning 101 and Juan Sequeda, principal scientist of data.world will present his UltraWrap NoETL patented technology.

Solving the unsolvable

The future of decision-making will render in blinks of an eye. Problems we thought unsolvable will suddenly have answers. Business leaders must get behind the leap of faith required for our own companies and push learning and understanding forward across the organization at all levels. AI and machine learning are the vortex of change. Are you ready for AI?

------

Suzette Cotto is CEO of Innovate Social Media, a digital marketing agency specializing marketing for startups in the medical, technology, and energy industries. For more information on DataCon Houston 2019, please visit: https://incitelogix.com/datacon-houston-2019/

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston robotics co. closes series B after year of growth

money moves

Houston- and Boston-based Square Robot Inc. closed a series B round of funding last month.

The advanced submersible robotics company raised $13 million, according to Tracxn.com, and says it will put the funds toward international expansion.

"This Series B round, our largest to date, enables us to accelerate our growth plans and meet the surging global demand for our services,” David Lamont, CEO, said in a statement.

The company aims to establish a permanent presence in Europe and the Middle East and grow its delivery services to reach four more countries and one new continent in Q1 2025.

Additionally, Square Robot plans to release a new robot early next year. The robot is expected to be able to operate in extreme temperatures up to 60 C. The company will also introduce its first AI-enabled tools to improve data collection.

Square Robot launched its Houston office in 2019. Its autonomous, submersible robots are used for storage tank inspections and eliminate the need for humans to enter dangerous and toxic environments.

The company was one of the first group of finalists for the Houston Innovation Awards' Scaleup of the Year, which honors a Bayou City company that's seen impressive growth in 2024. Click here to read more about the company's growth.

------

This article originally ran on EnergyCapital.

Show me the money: Top Houston innovation grant and gift news of 2024

year in review

Editor's note: As the year comes to a close, InnovationMap is looking back at the year's top stories in Houston innovation. Money means a lot to startups and other innovative entities, and while startups are usually scouting venture capital investors, grants and donations are key too. These are the most-read news articles about grants and gifts — be sure to click through to read the full story.

Rice researchers secure $35M federal grant to advance medical device technology

Rice’s Biotech Launch Pad will lead the effort to commercialize the device. Photo courtesy Rice University

Rice University has secured part of a nearly $35 million federal grant aimed at commercializing a bioelectric implant for treatment of type 2 diabetes and obesity.

The federal Advanced Research Projects Agency for Health awarded the $34.9 million grant to Rice and several other universities.

Rice’s Biotech Launch Pad will lead the effort to commercialize the self-contained, implantable Rx On-site Generation Using Electronics (ROGUE) device. ROGUE houses cells that are engineered to produce type 2 diabetes and obesity therapies in response to patients’ needs. Continue reading.

Houston health care institutions receive $22M to attract top recruits

The grants, which are between $2 million to $6 million each, are earmarked for recruitment of prominent researchers. Photo via Getty Images

Houston’s Baylor College of Medicine has received a total of $12 million in grants from the Cancer Prevention & Research Institute of Texas to attract two prominent researchers.

The two grants, which are $6 million each, are earmarked for recruitment of Thomas Milner and Radek Skoda. The Cancer Prevention & Research Institute of Texas (CPRIT) announced the grants May 14.

Milner, an expert in photomedicine for surgery and diagnostics, is a professor of surgery and biomedical engineering at the Beckman Laser Institute & Medical Clinic at the University of California, Irvine and the university’s Chao Family Comprehensive Cancer Center. Continue reading.

New report ranks Houston top market for life sciences

Houston lands in the No. 7 spot for growth in the granting of degrees in biological and biomedical sciences. Photo by Natalie Harms/InnovationMap

Thanks in large part to producing hundreds of college-trained professionals, Houston’s life sciences industry ranks among the top U.S. markets for talent in 2024.

In a report published by commercial real estate services company CBRE, Houston lands in the No. 7 spot for growth in the granting of degrees in biological and biomedical sciences. From 2017 to 2022, Houston notched a growth rate of 32.4 percent in this category.

In 2022, the University of Houston led the higher education pack in the region, graduating 746 people with a bachelor’s degree or above in biological or biomedical sciences, according to the report. Continue reading.

Texas organization grants $68.5M to Houston institutions for recruitment, research

Several Houston organizations have received millions from the Cancer Prevention and Research Institute of Texas. Photo via tmc.edu

Three prominent institutions in Houston will be able to snag a trio of high-profile cancer researchers thanks to $12 million in new funding from the Cancer Prevention and Research Institute of Texas.

The biggest recruitment award — $6 million — went to the University of Texas MD Anderson Center to lure researcher Xiling Shen away from the Terasaki Institute for Biomedical Innovation in Los Angeles.

Shen is chief scientific officer at the nonprofit Terasaki Institute. His lab there studies precision medicine, including treatments for cancer, from a “systems biology perspective.” Continue reading.

Houston health care institution secures $100M for expansion, shares renderings

Baylor College of Medicine's Lillie and Roy Cullen Tower is set to open in 2026. Rendering courtesy of SLAM Architecture

Baylor College of Medicine has collected $100 million toward its $150 million fundraising goal for the college’s planned Lillie and Roy Cullen Tower.

The $100 million in gifts include:

  • A total of $30 million from The Cullen Foundation, The Cullen Trust for Health Care, and The Cullen Trust for Higher Education.
  • $12 million from the DeBakey Medical Foundation
  • $10 million from the Huffington Foundation
  • More than $45 million from members of Baylor’s Board of Trustees and other community donors, including the M.D. Anderson Foundation, the Albert and Margaret Alkek Foundation, and The Elkins Foundation.

“The Cullen Trust for Health Care is very honored to support this building along with The Cullen Foundation and The Cullen Trust for Higher Education,” Cullen Geiselman Muse, chair of The Cullen Trust for Health Care, says in a news release. “We cannot wait to see what new beginnings will come from inside the Lillie and Roy Cullen Tower.” Continue reading.

TMC launches cancer-focused partnership with Japan

global collaboration

Houston's Texas Medical Center announced the launch of its new TMC Japan BioBridge and Japan-Accelerator Cancer Therapeutics and Medical Devices, or JACT, this month.

The strategic partnership between Japan-based Mitsui Fudosan Co. Ltd. and the National Cancer Center will focus on advancing cancer treatments and providing a pathway for Japanese innovators to expand in the U.S. market. A delegation from TMC recently visited Tokyo, and William F. McKeon, president and CEO of TMC, signed the TMC Japan BioBridge Memorandum of Understanding with Takeshi Ozane, general manager of Mitsui Fudosan, and Hitoshi Nakagama, president of the National Cancer Center of Japan.

“The launch of TMC Japan BioBridge is a vital step forward in connecting two global leaders in healthcare innovation,” McKeon says in a statement. “Japan’s leadership has demonstrated an impressive commitment to advance medical cures and life sciences technologies and through this partnership, we are opening necessary doors for Japanese researchers and innovators to access the US market and collaborate with our TMC ecosystem. Together, we aim to accelerate critical breakthroughs to make a difference for patients all around the world.”

The new JACT will offer cancer-treatment companies a structured process to prepare for a U.S. expansion and will allow for meetings with pharmaceutical companies, hospital systems and investors and provide insights on U.S. regulatory approvals. It'll focus on three key areas, according to the statement:

  1. Milestone development and financial planning
  2. Clinical and regulatory expertise
  3. Strategic partnerships and market insights

“This TMC Japan BioBridge and JACT Program will enable us to promote the advancement of start-up companies aiming to commercialize innovative medical technologies originating in Japan into the U.S." Nakagama says in a statement. "We also hope this collaboration will not be limited to our (Japan Agency for Medical Research and Development)-supported project, but will lead to further cooperation between TMC, NCC, and other Japanese institutions in various fields.”

This is the sixth international strategic partnership for the TMC. It launched its first BioBridge, which focus on partnerships to support international healthcare companies preparing for U.S. expansion, with the Health Informatics Society of Australia in 2016. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.